INS and steatosis: Perhaps more important is the apparent protective effect of NNRTI containing regimens, which could be ascribed to better tolerability and metabolic profile of this kind of therapy.[29] We hypothesized that containment of insulin resistance and lipid increase attributed to these regimens may have given some benefits to the liver of our patients in terms of steatosis, slowing down progression of LF.